U.S. Markets closed

Vical Incorporated (VICL)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.66+0.01 (+0.37%)
At close: 3:59PM EDT
People also watch
BCRXHEBLGNDXOMAPGNX
Full screen
Previous Close2.65
Open2.57
Bid0.00 x
Ask0.00 x
Day's Range2.56 - 2.73
52 Week Range2.05 - 4.50
Volume40,127
Avg. Volume75,523
Market Cap29.52M
Beta0.91
PE Ratio (TTM)-2.98
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube23 days ago

    ETFs with exposure to Vical, Inc. : June 30, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cubelast month

    ETFs with exposure to Vical, Inc. : June 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vical, Inc. Here are 5 ETFs with the largest exposure to VICL-US. Comparing the performance and risk of Vical, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vical, Inc. :VICL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017
    Capital Cubelast month

    Vical, Inc. :VICL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Vical, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Vical, Inc. – CytRx Corporation, Newlink Genetics Corporation, Chimerix, Inc., Agenus Inc., Celldex Therapeutics, Inc., Pfizer Inc., Merck & Co., Inc. and Bristol-Myers Squibb Company (CYTR-US, NLNK-US, CMRX-US, AGEN-US, ... Read more (Read more...)